Annex

United Kingdom

Permitted health claim

Application — Relevant provisions of Regulation (EC) No 1924/2006	Applicant — Address	Nutrient, substance, food or food category	Claim	Conditions of use of the claim	Conditions and/or restrictions of use of the food and/or additional statement or warning	EFSA opinion reference
Article 14(1)(a) health claim referring to a reduction of a disease risk	Cargill Incorporated, acting through Cargill Health and Nutrition, c/o Cargill R & D Centre Europe, Havenstraat 84, 1800 Vilvoorde, Belgium	Barley beta-glucan	Barley beta-glucan has been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease.	Information shall be given to the consumer that the beneficial effect is obtained with a daily intake of 3 g of barley beta-glucan. The claim can be used for foods which provide at least 1 g of barley beta-glucan per quantified portion.		Q-2011-00798
Valens Int. d.o.o., Kidričeva ulica 24b, SI-3000 Celje, Slovenia	Q-2011-00799

Application — Relevant provisions of Regulation (EC) No 1924/2006

Applicant — Address

Nutrient, substance, food or food category

Claim

Conditions of use of the claim

Conditions and/or restrictions of use of the food and/or additional statement or warning

EFSA opinion reference

Article 14(1)(a) health claim referring to a reduction of a disease risk

Cargill Incorporated, acting through Cargill Health and Nutrition, c/o Cargill R & D Centre Europe, Havenstraat 84, 1800 Vilvoorde, Belgium

Barley beta-glucan

Barley beta-glucan has been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease.

Information shall be given to the consumer that the beneficial effect is obtained with a daily intake of 3 g of barley beta-glucan.

The claim can be used for foods which provide at least 1 g of barley beta-glucan per quantified portion.

Q-2011-00798

Valens Int. d.o.o., Kidričeva ulica 24b, SI-3000 Celje, Slovenia

Q-2011-00799